Our Science
Our technology will bring new medicines for diseases of unmet clinical need
Many publications have appeared in prestigious scientific journals explaining the innovation from the research groups of Naismith and Jaspars that underpins GyreOx's technology. Key ones include:-
(1) “Structural analysis of leader peptide binding enables leader-free cyanobactin processing”, Koehnke et al., Nature Chem. Biol.., 2015 Aug, 11(8), 558 – 563, doi: 10.1038/nchembio.1841
(2) “Synthesis of hybrid cyclopeptides through enzymatic macrocyclisation”, Oueis et al., Chemistry Open, 2016 Dec 13, 6(1), 11 – 14, doi: 10.1002/open.201600134